And Oppenheimer upgraded shares of Questcor (QCOR) from perform to outperform as Acthar will drive growth in the near-term, despite concerns regarding competition. With the upgrade, Oppenheimer set a $57 price target. Shares of Questcor were lower by 4.9% on Friday.
Quick, who do you trust more: B of A or Oppenheimer? Do you prefer sauerkraut or ice cream?
They may all say what they will, but Q2 earnings will settle any differences. And my money is with Q2 earnings.
actually Oppenheimer reinstated there coverage of QCOR with an outperform. They had suspended coverage around last Oct when all the turmoil was going on. Glad to see them back. I'm hoping we see targets raised after the 2nd quarter blowout of revenue's and earnings
Oppenhemer Funds are not related to Oppenheimer & Co nor have they been under the same corporate umbrella for many years. CIBC in Toronto used to own the Oppenheimer & Co brokerage business but sold it for pennies on the dollar to Fahnstock & Co (a regional second-tier firm) which then took on the more recognizable Oppenheimer name. Oppenheimer & Co. has limited reach & market share, certainly among institutional investors.